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:.ngrn perubahan pada pl6 dan pRb ( secara spesifik paling sedikit 60% dari seluruh kasus) dibandinCkan
:efcan p5:l (yan8 kuung dari 20%). Nanrun de'nitian- di sebagian besar belahan dunia. SCC dianggap
.rr!.bibkan oleh asap ternbakau dan alkohol. yang menimbulkan suatu efek sinergistik bila digunakan secara
\oJnbinasi. Perubahan-pcrubahan spcsifik yang umum terjadi (50-100%) adalah pada gen supresor p53.
\plikasi pe ring dari gen-gen. ekspresi protein s€rta penanda lain yang berhubungan akan dibahas secara
: .ngkat .
I  nlroduction
Oral squamous cell carcinoma (SCCI) is
'-:1r most common fonn oI oral cancer. which
r fie si\th most conxnon malignancy world-
.rde represenling 5.6% of new cancer cases
-d 5.19n of al l  cancer deaths.r  SCC rs
:fiiculad) resistanl 1() therapeulic treahnent:
:\.uI -10-509/0 of the cases are fatal within 5
r:iri oi tirsi diagnosis.: llntil recentlv. there
_-.:. been litllc changc in thc relativc survi\al
- : . < .  . I l r ! (  l q i 0  '  l , r  t r r n h e r  p r o g r e \ s .  i r  i .
: ..1r1! imporlant lo belter undersland the
:+;hanisrns thal lead to oral tumors and
- :nrrol thoir progressjon.
oral canccr is thought to be pre
::nrnantly initiatcd and promoted by the
:'_enrcal insult from oral exposure to certarn
-:r iogical  agents. such as tobacco. ethanol
rc,: betel quid.rj other contributing though
F!! rniluential factors appear to include viral
:.:.!lilrns. poor oral h)'giene. consumption of
r.ilrted lats and deficiencies in vitamins A
d L. and iron.61{e A rare inh€rited genetic
G-i.rder. Fanconi s anaemia. can also induce
ira .ancer bul probably more important
Eoented lictors are the inteFindividual
r:n.rn,.ns rn sensilivily to carcinogens." As
= r:nems ofpredisposing factors can difi'er
r ;3rlous parts of the world. so do the
a:::ence and other characteristics of' oral
.-..r The genelic and molecular pathways
E rrtrl cancer can be expected to show
arr:sp.'rrling regional differences.
Ihc .arl]' prcmalignant phascs of SCC
--.-:irrn resull in fie development of lesions
- =.r i.,rrr of leukoplakia (white patches) or
s-a-:rnplakia (red patches). which can
d:rr \ar\ing dcgrccs of hyperplasia or
+s:irr Lcukoplakia is much more
common but erythroplakia is a more potenl
precursor oforal squamous cell carcinoma; rn
thct histopathological examination of the
lafter typ€ of lesions suggests that about half
ol-  lhcsc lesions are acmal lv invasi!e
sqrurmoLrs cell carcinomas.' Of advanced but
prcmalignant dvsplastic lcsions. 36010 on
avarage have been fbund to lransform to a
nalignant state within 8 years in IISA.r' 
There are many oncog€nes. or genes
\\,hich \\'hen inappropriately activated,
amplified oi inactivated can promote som€
tbrm of cancer: more than 100 oncogenes
have been identified.'r '' However, cancer ts
a multistcp process where singular gene
alterations arc necessary but not sufficient for
caicinogenesis. and diflerent genelic events
are involved in the initiation, promotion,
proglession and m€tastasis stages of cancer.
Ilased on epidemiological, molecular and
stalistical studies it has b€en suggested that 6
to 10 genetic events are required for oral
cancer. 5 In most cases, mechanisms ofDNA
repair and apoptosis will deal with the
deviations from normal cellular functio!.
Cancer is more likely with addilional
dysfimction, i.e. inappropriatc activation or
silcncing of the tumor suppressing genes
(anti-oncogenes) which control some critical
events of the cell cycle, including the
proce\scs of DNA repair  and apoprosis.  l t  is
the purpose of the present paper to elucidate
the role ol  lumor suppre\sor genes in
oncogenesis of oral squamous cell
carcinomas- Below. a hriefrcview is given on
the rol€ of the tumor suppressor genes in the
oncogenesis of oral SCC.
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Observed Pa(terns of SCc oncogenesis
and Alterat ion ofTumor Suppressor
Genes
In lrurope. IrSA- Japan. China and
,^ustralia thc main eslablishcd etiological
agents oforal cancer are smoked tobacco and
alcohol (ethanol). \\'hich are known to exert a
disproportionately stronger cffect when used
in combination. The syncrgy is thought to
arise sequentiall), so that ca.cinogenic and
cocarcinogenic chemicals from tobaoco
induce DNA damage and ethanol promotes
its progrcssion by immunosuppressive aclioD
and by preventing damage fron being
repaired. lhe carcinoma is rypioally found
eilher endophytically in the trough formed b-v
the lateral border of the tongue. moulh lloor
and the lingual aspecl of the lower al\eolus
(possibly due to local pool ing oi
carcinogens). or in case of tobacco chewiirg.
exophytically at the sile of applicati('r.
frequenlly in the buccal sulcus and buccal
mu\o) i .   rul  (dn\er rs m,,re LUlrun, 'n in
males than in femalcs. and the incidence ratc
incrcases sharpl) aftcr about 4G50 years ol
age. ln Europe. [JSA. Japan and Australia
about l -2% ofal l  canccrs are oral  in or igin.r l
In Europe. USA. Japan and Llhina oral
carcinomas show a high prevalence of
mutations and altelic loss in the importanl
tumor suppressor gene pJJ (Fig la). the
reported incidence varying generally from
about l0% 1l) 95%.16 16 Mutations have becn
mostly reported from a range of codons from
exons 4 lc) 9. with highest fiequencies in hot
spots heilv€en codons 100 and 300.
Particularly common are mutations A +G.
(;JA, G-+T and (' + I (lrig lb.). Ol these. ai
least G+l mulalions are typical for tobacco
deri !e, l  car( inogens 'u.h u. b.nrpyrcne. ' -
The studies reporting highest incidcncc range
(90% or more) of mutations lend to be more
recent and io employ direct sequencing of
nRNA fbllowed by additional DNA
sequeDciig. The sane nrethod also shows
higher concordance between primary tumors
and lymph node metastases, and 100%
(oncordance has been reponed when using
addit ional ly murat ion specif ic ol igo l igal ion
assay. This suggests that the pJJ mutations
arc stahle in the progress of cancer.r6 Also
DNA viruses such as human papilloma virus
(HPV) can bind to and potentially inactivate
pJJ. As piJ has multiple important roles (see'Iable I ) in regulating cell proliferation, DNA
rcpair and apoptosis, its inactivation can lead
to cancer in a wide range ot t i$ues including
those ol the oral cavi4.rI3 Alterations of
p53 can b€ already present in pre-malignant
lcsions. in about l5% of leukoplakiasr '2 '  and
30-50% of erythroplakias.r')
Frequent inactivalion of the tumor
suppressing p16 gene has been rcponed for
primary tumors and metastases of oral SCC
and also from about ,10% of premalignant
lesions.rrr :  The pl6 protein regulates cel l
proliferaljon b] binding to cyclin-dependent
kinascs (CI)K) .1 and 6. inhibi t ing the
catalytic actilir)- of the CDK-cyclin D-l
complexes 6t the Gl/S intertac€ by
phosphorylalion oI pRb in the retino-
blastoma (Rb) pathway. Allelic loss and
nrutations ofp16 have been observed in 70-
80% of SCC tumors-''rttt However. in at
least 20-10% oI the reporled cascs of SCC,
p/6 is nol expressed in spite of a nomal and
intact gene. This is apparently due to DNA
methylation at a specific 5 CpC island ofthe
gene. ln cultivated SCC cell lines the
tiequency of altered pl6 can reach 100% but
is often observed to be lower in primary
tumors. The difference may be partly due to
mutations in culture, partly du€ to techniques
used in assessing the altered ftequency.r' Of
the two ahemative lranscripts (c[ and B)
coded by p/6. the [] transcript gives rise to
thc pl4ARf protein. which by binding to
MDM2 leads to stabilization and accumu-
lation of tumor suppressing p53. However,
rhe c( l ranscr ipl  \ \hich (arr ies the main
function of p/d is much more commonly





! ! 1. a) Reponed frequency of p5-l muialions nr SCC tunors in Ewope, USA,
, lEctFchina) and in South and South-East Asia (S&SE A.ia)r6bF4i6
-rrnionvlransversiors in human oral SCC tumors (redrawn fiom the review dala of[4]).
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{ different path of carcinogenesrs
rlpellrs to occur in the well djfibrentiated
:- l  \errucous carcinoma 1VC). which shows
- r melaslasjs although it is originally
:e.!nbcd as a subclass ofSCC. VC is though
: be initiated by IIPV virus' 5, and the
_srulting tumor expresses the p16 protern
:u.h more slrongly (and p53 less) than usual
\  t  {  |  iC 2 r .  \ l ier emergence of metastasi . .
:c prognosis of SCC is worse but even at
-  .  . r .1s< lhere i .  dr Icasl  onc (haraclcr i5t i (
-rn. ' r  .upprcs' ing gene. l l , r  2J. which i '
_:r . 'uehr ro eode the NDP kinase inrohed in
=isfer of terminal phosphate from a
:l)(leoside triphosphate to NDP.rr
fhe p)6 gene is functionally
:.'rnplementary to pRr. which can also be
:+en as a tumor suppressor gene. In normal
:elli acli\e pRb prevents cellular fiansition
-:,m Gl to S phase by sequestering the
_e.e\$r) transcription tactors. The pRb
,-,.rein can aiso bind with the IIPV
:{FLrproteins E6 and E7. and high pRb
:\nr<\\ron logclher ui lh high le\els ol  pl6 is
: .rrcal  in l lPV-induccd VC.tt  In contrast.
'-n.rional inhibition of pl6 but elevated
:rr'ression of pRb can be observed in usual
::rrns of SCC. particularly in terms of the
lensrtl ofthe protein expression (Fig 2b).r'
Another suggested tumor suppressor
gene is p1J0. which is structurally and
lunctionally a relative b pRb. and therefore
also involved in cell cycle regulation in the
Gl phase. with affinity to CDK2. lnmuno-
histochemical aclivity of pl l0 is seen in th€
nuclei and milochondria.'3 Allelic loss in
p/Jo has been reported in many forms of
cancer. and p/Jo is apparently panicularly
alfccted in poorly differentiated forms of
SCc 0' is 3).r l
tn lndia. Sri Lanka, Papua New Cuinea
and parts of Southeast Asia including
Indonesia and Taiwan, a particular agent
carrying a high risk to oral cancer is chewed
tobacco in the form of betel quid. Thrs
consists of areca nut (prrang) and lime, with
or without and tobacco and spices, wrapped
into a leaf of the betel vtne (Piper betle,
si/ir)- Exophytical origin of oral cancer rs
then common, often in the buccal regions.
llabitual use ofthe betel quid is lhought to be
lhc main reason for oral cancer in Soud Asia
accormting for 18-40% of all malig-
Generally less than 2070 of the
'nalignant oral tumors have been reported to
show mutations in the piJ gene in South and
South East Asia where betel quid rs
15
t:l1r thruhDn 4trrktrt attNn!ltrhatr"r du hkt|rn t)tatr1
habitual l )  used (f  ig la).r !ar a: . | .aaa5 Insread,
trequent (15%) murations of the H-rlu gene.
loss of hcterozvgoiil\ at lhe l/-/ar locus
{:10%), some mutation of the /(-/as Eene(7%). as rvell as amplification of /V-ra,
128'ro). N nyc 129%). bcl-2 (23o/o). c t ttt..
l20o/o) and K-ft1s (l7o/r) oncosenes have becn
oDrr!ed '  thr\  nrul l ipt ic i i )  ol  genetrc
aileraaions appears characteristic for b€r€r
qujd users. probabl) reflecring rhe severity of
chemical attack. Thc /.as t'ainil) of
oncogenes. ollcn in\olved carl)' in the
lormation of chemically induced cancers.
r ( . " 1 r  i n  i h n o n n J l  C  f r o r ( i n .  s h i r h  I n
'rormal cells regularc the infbrmation
exchange across the cell membrane.rr Tnc
bcl-J oncogenc expression inhibits both p53-
dependent and p5 t- independenl apoptosis
pathways.' the c z./c oncogene is involvect
both in driving rhe cell cycle and In
apoptosis. depending on the level of rne
growrh factor IGFI.ar Overexpression ofp53
has also b€en reporled but is not well
corelated with incidence of mutations.ara3
npparently p53 is inversety expressed with
resp€ct to bcl-2 so that taken together, about
40% of Indian SCC cases may involve
d\sl-uncr ional apoprosis palhwa] eirher r ia
p53 or bcl-2.{ Perhaps more importanu}.
trequent loss ofboth p/6 and pnb expresslon
have becn r€porled in SCC tumors and pre_
nalignanl leukoplakias of betel quid users

















l j rg : l  a lLosso iexpresroro fpr : r .ahdpRbnonrs(c1r t rno6 ra l r  s (c  cas .s  and le r .  n .derarery  and pmrr t  d r ta renna.druhr' dd n nomar d.r r,sue (,ednwn lio'h dda of []8r on r,paresc sobj€crs) Nore rhar ross or expreison dr pRb u much r6sli,Ll:i:i;1f.f*ill1il,:*i":.fJt.i.fj:_:t,i.jji,5iifl:".il::lj,':1il1trt?.,::jil:ti""a.*i" r, r'.o,i.."r"ir#.Ji
'16
lr,ri \Vptulnon tnOtuoAtru's 4 Oal SquDowl:ell CarctnMd
\ .reof lhecharacler ist icsofobservedoncogencsandtumorsupPressorgenesassociatedwithoral
\ a are summarised in Tables I and 2.
:r . I Chrcmosomal location and carcinogenetic Inechanisms ofso'ne recognized oncogenes and ann-
oncogencs (tumor suppressor genes) rerated lo oral cancer'rr1rl
: i , d I h t l I  i n t - 2
I A .  P M
IA. PM
IA. IL
]A. PM. AI, .  M
PN,I.  IL
IA. PM
I. IA. AI, ,  PM
I. PM. At,
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.srcnogeDcsrs: rA : 'naPPtol'I'aE dluLttr
;  o \s -  l l -  =  t rans loca t ion .  M =  nre th l la t ion
i : I i ppropriate aclilation/amllilicalion. I =ilicalion.  inactivarion. PM = point nulation, AL =
:. terrures ol kno\]l lumor suppr€ssof genes associatcd with oral SCC 
5 ir 15 rl
Notes
IndLrlion of p21 lbr DNA repair or
replication ofcells with danraged DNA
o transcript: inactivales cyclin D-dependenl
are needcd tbr phosphorllalion ol pRb
rhough Gl /S
apoptosis; bhck of Alter€d in many types of
tunors including SCC
: ll| Cell cycle regulation. specific tbr Gl phase.
CDK2. slructural/tunctional similaritv to r'RF
kinascs ,l and 6 thai
to 'n€drate passage
lnactivaled (c!) in many
t)?es of lumors including
SCC
Allelic loss in nany forms
Inaclivated in many lw€s of
tumors including SCC
Reduces (in wr-o form)
metastatic polential in some
wirh affiniry io
:Rt, When aclivated. suppress€s cell proliferation bv iniibiting Gl/S
rransilion via scquestering transcription factors like E2I
-r:jl Encodes NDP kinase involved in transftr of lenninal phosphate
frorn a nucleoside triphosphate oNDP
(Xher Related Gene/ Protein Markers
r i th Potent ial  Cl inical  Signif icance
{part from thosc listed above. there is a
.rJe range of cell cycle related proteins that
:r !ho\ imporlant reactions to the status of
rr  \ r  I  .  Ior c\dmnlc. lhc ant igcn pn,t( in
r:-n. is a proliferation marker that is active
in all phases of the c€ll cycle except U0
Increased Ki{7 expression has been reported
as an indicalor of fn ' l i ferat ion act iv iq (Fig
4a) in pre-malignant and malignant
lesions.ttoqt" However. the marker efficien-
17
t:]:u lhruhh A,.tkr/ Aso.nc l).nutrrt tan tvdur"t rauta
c) shows considerable scafter and the marker
can also lail to reoect the prolifirarion rate of
the tumor. because differcnl antibodies oi'
hetcrogeneous cell populations recognrTc
different cpitopes ol rhe antigeD.'rl
I h e  (  D K  i '  l i b r r i , r  n 2 l  h a \  a  r , , t e  i n
pre!entrog Ihe l ,ansrrron fr , rm Cl ro s
phase. '  l  \nreision ol  p 27 genera ]
de( lea.es uiLh rncrcased ccl l  prol i fcml ion
and is inversclJ, relatcd to Ki-67 expression.r5
Significantly clevated apoptotic inde\ nas
been reponed in p27 positive SCC rurnors.:
and hence p27 mav be able ro slo\a down
canccr progrcssion. Ilowerer. generally p27
is less intensivel] expressed in SCC ceus
than in nomral oral rissue (Fig 4a), and lack
of p27 expression nay be associated wrm
The mechanisms of carcinogenesis of
oral SCC are similarly complex as in al
cancers. with central role attributed b thc
accumulating danrage inflicted by the
etiological agents on the genetic and
molecular regulation of the cell cycle. llle
observed large difference in the incidcnce ot
oral SCC bel\'reen Southenl/ Southeasteru
poor prognosrs. I he coffesponding gene p2-
rs not senstllve to mutations. bul adenovirus
EIA and human papillomavirus (HpV) E7
can block the benef ic iat  acr ion ofp27.5?
Ihe apoplosis regulal ing protein Bax rs
a negative regulator ofBcl-2 and is therefor€
usually inverseiy distributed in normal
tissues with respecl to Bcl-2.53 Ovcr_
expression of Baxs enhances apoptosis by
modulating the p27 protein levels.r Based on
erperimenral  e\ idenre on tnouse SCC { l- ig.1h) it has been suggested that exogenous
administcring of the dr gene in association











f-ig.4 a) Ijraction ofce s expressing the proteins Ki-67 and p27 in orar vc and scc hunors and rn pre-nnugnant nroderdte dysptasja (from data of [25]). b) Etlacl on lunor size of gene gun injecrron ol lhe baxgene with and without chenrctlerapy (CDDP or cisptarin) iDirially and after r.l aays i+ ttearrnents; in micernoculated with S(lC cells 7 days before lherapy (film dar, ofl5dl).
Conclusive Remarks
Asia and the rest of the world reflects the
respective DNA damaging action of the
carcinogenic chemicals in chewed betet quid
and smoked tobacco. Important part of the
damage affects the tumor suppressof genes.
ot which p5J and pt6 arc particularly
sens,tive to alteration by mutafions, allelic
kxs and methvlation. With the development
OStar l
78
: :  e l f ic ient anal] ,s is techniques. ful l
,lntificalion of the DNA alt€rations io oral
!:( tumors has onl)- recently become
:.r:sible.
\ l lhough man) delai ls of  rhe generi(
! \ l  -n. lccr lar rnechanisms uf (arcinogenesis
ral rts supprcssion remain poorly known. the
.\-n alilrns made so far hold promise tbr
: : : r .al  appl jcat ions both in diagnosis and
i:i.nlial therapy. Furthcr research is needed
r.--.-fe rew applications can make d
r.._ iicant contribution to the cunently
-glrnar ing rherapeut ir  methr-rcls of i r -
*:rion. surgery and chemotherapy. which
r rs-gressive combination have recently
-Eyr\ ed ihe 5 vear survival rutes of oral
l|. ,- nr aboul 80%.5i Posili\e contributiur
GLi bc much n€eded. ho*ever. lbr cases
*i. Jo not respond weli to con\cntional
rtl:l In particular. impro\'ed sunival
Fi.:rrlrt' can be expected, ilthe incidence
- :-:.atplete remission in the therapeutic
Earcnl \\ere to increasc,ir (lurrenl sur,.
I 3res arc lo$cst and recuftence ratcs
I r"r', Su telstm th Onusen ta rl (nd Sqwo6 a.ll CdrctrMa
I he new developments have also opened
n€w ways towards cancer ch€moprevention.
where specific drugs are administered to
suppress carcinogenesis and to prevent the
development of invasive cancer. Although
larger scale confirmation is needed,
promising results have been obrained by
using l3-cir-retinoic acid. which in a limited
study resulted in a six-fold d€crease in the
rurc ol  dr\c lopmenl ot second pr imarl
tumors."' Equally imponanl are develop-
ments to improve the therapeutic trealrnents
of diagnosed oral SCC. Such promising but
as yet experimental methods to enhance the
ef'ficiency of chemotherapy includ€ e.g. gene
therapv by gene gun injection of the ,.rI
gene51 to the scc tumors to promoae aumor
cell apoptosis.
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